Search
Displaying 311–320 of 726 for “retinal diseases”
-
Eye Care Professional Resources
Contact the Foundation to receive notification of our webinars for eye care professionals and the latest updates on research and resources for inherited retinal diseases.
-
SparingVision Raises €44.5 Million for Gene-Independent RP Therapy
Research NewsThe company is planning a clinical trial for its emerging neuroprotective treatment in 2021
-
Eye Disease Studies Suggest Mediterranean Diet is Good for the Brain
Research NewsA healthy diet is also important for people with retinal conditions
-
Giving through your donor-advised fund (DAF) is a powerful way to help the Foundation Fighting Blindness find treatments and cures to blinding retinal diseases.
-
Beacon Stories
Dr. Marciello doesn’t let a Stargardt disease diagnosis get in the way of his twin passions: medicine and baseball.
-
Beacon Stories
Jen Walker was diagnosed with retinitis pigmentosa at 14 years old and didn’t feel ready to meet others with retinal diseases until many years later. Jen now wants to connect with others and raise awareness for the fighting blindness community.
-
Individual Investigator Research Award (IIRA)
Individual Investigator Research Awards are designed to concentrate research in areas with the greatest potential to move toward treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration. This award provides approximately $100,000 per year up to three (3) years. These opportunities seek candidates that hold a Ph.D., M.D., M.D./Ph.D., D.M.D., D.V.M., D.O., O.D., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.
-
Resource
Dr. Jacque Duncan, UCSF Professor of Clinical Ophthalmology, is currently working on therapies restoring vision for retinal degenerative diseases. Dr. Duncan has hope and optimism for the future that vision will be restored for those with retinal diseases, thanks in part by the Foundation’s work.
-
ARVO 2019: Emerging Drug for RP Evaluated in Safety & Tolerability Study
Research NewsFrancois Paquet-Durand, PhD, chief scientific officer at the company Mireca, discusses an emerging drug for retinitis pigmentosa, and other inherited retinal diseases.
